Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

bayer new zealand limited - nifedipine 33mg (active blend) - modified release tablet - 30 mg - active: nifedipine 33mg (active blend) excipient: cellulose acetate hypromellose   iron oxide red macrogol 3350 magnesium stearate as 0.4mg in active blend, 0.2mg in osmotic blend opacode black s-1-17823 opadry pink oy-s-24914 polyethylene oxide sodium chloride - treatment of coronary heart disease

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

bayer new zealand limited - nifedipine 66mg (active blend) - modified release tablet - 60 mg - active: nifedipine 66mg (active blend) excipient: cellulose acetate hypromellose   iron oxide red macrogol 3350 magnesium stearate as 0.8mg in active blend, 0.4mg in osmotic blend opacode black s-1-17823 opadry pink oy-s-24914 polyethylene oxide sodium chloride - -treatment of coronary heart disease -chronic stable angina pectoris (angina of effort) - treatment of hypertension

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

bayer new zealand limited - nifedipine 90mg - modified release tablet - 90 mg - active: nifedipine 90mg excipient: cellulose acetate hyprolose hypromellose   iron oxide red   macrogol 3350 magnesium stearate polyethylene oxide propylene glycol sodium chloride titanium dioxide

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

bayer new zealand limited - moxifloxacin hydrochloride 436.8mg equivalent to 400 mg moxifloxacin - film coated tablet - 400 mg - active: moxifloxacin hydrochloride 436.8mg equivalent to 400 mg moxifloxacin excipient: croscarmellose sodium hypromellose iron oxide red lactose monohydrate macrogol 4000 magnesium stearate powdered cellulose titanium dioxide - avelox tablets and solution for infusion is indicated for the treatment of the following bacterial infections caused by susceptible strains: · bronchitis (acute exacerbations of chronic bronchitis)

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

bayer new zealand limited - moxifloxacin hydrochloride 436.8mg equivalent to 400 mg moxifloxacin - solution for infusion - 400 mg - active: moxifloxacin hydrochloride 436.8mg equivalent to 400 mg moxifloxacin excipient: hydrochloric acid sodium chloride sodium hydroxide water for injection - avelox tablets and solution for infusion is indicated for the treatment of the following bacterial infections caused by susceptible strains: · complicated intra-abdominal infections including polymicrobial infections such as abscesses

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 1%{relative}; clotrimazole 1%{relative} - topical cream - 1 % - active: clotrimazole 1%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate active: clotrimazole 1%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - · tinea pedis (athlete's foot), tinea cruris (jock itch) and tinea corporis (ringworm of the trunk and limbs) due to trichophyton rubrum, trichophyton mentagrophytes, epidermophyton floccosum and microsporum canis.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 1%{relative} - topical solution - 1 % - active: clotrimazole 1%{relative} excipient: isopropyl alcohol macrogol 400 propylene glycol - · tinea pedis (athlete's foot), tinea cruris (jock itch) and tinea corporis (ringworm of the trunk and limbs) due to trichophyton rubrum, trichophyton mentagrophytes, epidermophyton floccosum and microsporum canis.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 10%{relative} (micronised ) - vaginal cream - 10 % - active: clotrimazole 10%{relative} (micronised ) excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate isopropyl myristate polysorbate 60 purified water sorbitan stearate - canesten clotrimazole thrush treatment once, 3 day and 6 day creams are indicated for the topical treatment of vulvovaginal candidiasis. canesten clotrimazole cream may also be used in conjunction with canesten clotrimazole vaginal pessaries in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 500mg (micronised) - pessary - 500 mg - active: clotrimazole 500mg (micronised) excipient: calcium lactate, hydrate as pentahydrate colloidal silicon dioxide crospovidone hypromellose lactic acid lactose monohydrate magnesium stearate maize starch microcrystalline cellulose - canesten clotrimazole thrush 1 day pessary and 6 day vaginal pessaries are indicated for the topical treatment of vaginal candidiasis.

Nýja-Sjáland - enska - Medsafe (Medicines Safety Authority)

bayer new zealand limited - clotrimazole 500mg (micronised); clotrimazole 1%; clotrimazole 1%{relative} - combination - active: clotrimazole 500mg (micronised) excipient: calcium lactate, hydrate as pentahydrate colloidal silicon dioxide crospovidone hypromellose lactic acid lactose monohydrate magnesium stearate maize starch microcrystalline cellulose active: clotrimazole 1% excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate active: clotrimazole 1%{relative} excipient: benzyl alcohol cetostearyl alcohol cetyl palmitate octyldodecanol polysorbate 60 purified water sorbitan stearate - canestan clotrimazole thrush 1 day pessary & cream is indicated for the topical treatment of vulvovaginal candidiasis. the cream can also be used in the management of candida vulvovaginitis or infection of the peri-anal area, while application of the cream to the glans penis of the partner may help prevent re-infection of the female.